The author discusses the launch of Eisai Inc.'s Lunesta, an insomnia drug, in Japan on April 18, 2012. The author states that the drug will be well received in the country due to its efficacy on sleep onset and sleep maintenance. Also, the author notes that Lunesta is considered the ...